Clinical Trial Update: Amelogenesis Imperfecta

View source ↗

Summary

A clinical trial investigating Amelogenesis Imperfecta (NCT01746121) has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amelogenesis Imperfecta

Snippet

Sponsor: University Hospital, Strasbourg, France | Conditions: Amelogenesis Imperfecta | Status: TERMINATED